Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype-Reference-Cited by-同舟云学术

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype

Published:2007-05-01 Issue:9 Volume:109 Page:1721-1728
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bauer Katrina R.,Brown Monica,Cress Rosemary D.,Parise Carol A.,Caggiano Vincent

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference46 articles.

1. American Cancer Society. California Facts and Figures 2006. Oakland, CA: California Division and Public Health Institute, California Cancer Registry; 2005.

2. . Demographic aspects of breast cancer incidence and mortality in California, 1988–1999. In: , eds. Breast Cancer in California, 2003 Sacramento, CA: California Department of Health Services, Cancer Surveillance Section, July 2004.

3. Racial disparities in breast carcinoma survival rates

4. Breast Cancer and Race: A Rising Tide Does Not Lift All Boats Equally

5. Ethnicity and Breast Cancer: Factors Influencing Differences in Incidence and Outcome

Cited by 1644 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Value of Metabolic Parameters in Pretreatment 18F-FDG PET/CT with Regard to Molecular Subtype, Immunohistochemistry, and Overall Survival in Primary Invasive Ductal Breast Cancer;TURK ONCOL DERG;2024

2. Diffusion Tensor Imaging for Characterizing Changes in Triple‐Negative Breast Cancer During Neoadjuvant Systemic Therapy;Journal of Magnetic Resonance Imaging;2024-01-31

3. Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer;Cell Death Discovery;2024-01-29

4. Design, development and bio-evaluation of a novel radio-ligand 99mTc-THQ-DTPA as a sigma 2 receptor specific breast tumor imaging agent;Bioorganic & Medicinal Chemistry;2024-01

5. Advanced nano-based strategies for mRNA tumor vaccine;Acta Pharmaceutica Sinica B;2024-01